Department of Biology, Pennsylvania State University, University Park, PA 16802, USA.
Int J Mol Sci. 2022 Aug 1;23(15):8528. doi: 10.3390/ijms23158528.
Polyploidy is common in cancer cells and has implications for tumor progression and resistance to therapies, but it is unclear whether it is an adaptation of the tumor or the non-adaptive effect of genomic instability. I discuss the possibility that polyploidy reduces the deleterious effects of loss of heterozygosity, which arises as a consequence of mitotic recombination, and which in diploid cells leads instead to the rapid loss of complementation of recessive deleterious mutations. I use computational predictions of loss of heterozygosity to show that a population of diploid cells dividing by mitosis with recombination can be easily invaded by mutant polyploid cells or cells that divide by endomitosis, which reduces loss of complementation, or by mutant cells that occasionally fuse, which restores heterozygosity. A similar selective advantage of polyploidy has been shown for the evolution of different types of asexual reproduction in nature. This provides an adaptive explanation for cyclical ploidy, mitotic slippage and cell fusion in cancer cells.
多倍体在癌细胞中很常见,对肿瘤的进展和对治疗的耐药性有影响,但尚不清楚它是肿瘤的适应还是基因组不稳定性的非适应性效应。我讨论了多倍体减少由于有丝分裂重组而产生的杂合性丢失的有害影响的可能性,在二倍体细胞中,杂合性丢失会导致隐性有害突变的互补迅速丧失。我使用杂合性丢失的计算预测表明,通过有丝分裂分裂并发生重组的二倍体细胞群体很容易被突变的多倍体细胞或通过有丝分裂内复制分裂的细胞、或偶尔融合的突变细胞所入侵,这会减少互补的丧失,或者恢复杂合性。在自然界中不同类型的无性繁殖的进化中,也表现出多倍体的类似选择优势。这为癌细胞中的周期性倍性、有丝分裂滑移和细胞融合提供了适应性解释。